Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation (Q82946218)
Jump to navigation
Jump to search
scientific article published on 13 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation |
scientific article published on 13 December 2011 |
Statements
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation (English)
Dietger Niederwieser
Myriam Labopin
Nicolaus Kröger
Per Ljungman
Mohamad Mohty
Emmanuelle Polge
Reza Tabrizi
Vanderson Rocha
Christoph Schmid
Arnon Nagler
Michael Stadler
Jürgen Kuball
Jan Cornelissen
Jiri Vorlicek
Gerard Socié
Lars Vindeløv
Graham Jackson
Andreas Rank
Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
13 December 2011